FAS and lymphoproliferative syndrome: Soluble Fas (sFAS) can antagonise cell surface FasL by competitive inhibition and so allow continued T-cell proliferation, a phenomenon shown to be significant in lymphoproliferative disorders such as non-Hodgkin’s lymphoma109.